Actos & Bladder Cancer
Orlando, FL (PRWEB) December 07, 2011
On June 15, 2011, the Food and Drug Administration issued a warning to those patients taking the diabetes drug Actos that use of the drug for more than a year could increase the risks of developing actos bladder cancer. As the drug remains on the market, The Actos Bladder Cancer Center at ActosCancer.com was launched to provide information to those taking the drug.
According to a Bloomberg article published on June 9, 2011, Actos was the most popular diabetes treatment drug in the world last year. Millions switched from competitor Avandia in recent years after studies in 2007 linked that drug to heart attacks and cardiovascular death.
Legal help is available for anyone who took Actos and has been diagnosed with bladder cancer.
On August 23, 2011, Pharmaceutical Business Review reported that Actos patients diagnosed with bladder cancer have already begun filing claims against the maker of the drug, Takeda Pharmaceuticals.
The recent FDA warning came after an early review of the results of a current ten year study ordered by the agency after questionable trial data. The French Medicines Agency also released results of a study this March which showed taking Actos for more than a year could increase the occurrence of bladder cancer by up to 40%.
The FMA study collected data from 155,000 patients who had taken Actos over a four year period, then compared the results to approximately 1.3 million diabetics who had not taken the drug.
Many who seek help from ActosCancer.com are shocked that the FDA has not yet issued a recall of Actos. While authorities in France and Germany quickly banned further use of the drug after the negative test results, the FDA has allowed it to remain on the market.
Both the FDA and the European Medicines Agency have issued strong warnings about the continued use of Actos, especially in those at risk of or diagnosed with bladder cancer.
While the FDA has claimed that it awaits the results of further testing before deciding on a recall, many point to the fact that the lobbying efforts of the drug industry are also stronger in the United States than anywhere in the world.
The FDA approved Actos for the treatment of type II diabetes in 1999. The June 9, 2011 Bloomberg article reported that Takeda Pharmaceuticals earned around $4.8 billion in 2010 just from the sales of Actos, its most popular drug. The company has not indicated any plans to stop selling it.
The National Cancer Institute reports bladder cancer has claimed more than 15,000 lives so far in 2011. However, since the disease often shows symptoms early, it is regarded as highly treatable. Treatment can require targeted chemotherapy as well as surgery to remove tumors or the entire bladder.
Since those with bladder cancer can face significant pain, long term disruption of bodily functions like urination and sexual ability, or even death, the damages can be substantial. Anyone affected by the disease after taking Actos is urged to contact a lawyer as soon as possible to learn their legal options.
Drug injury claims can be complex, expensive and time consuming legal matters. Therefore, if you have been diagnosed with bladder cancer after taking Actos, it is important to make sure you choose an actos lawyer who is highly qualified and has experience fighting large drug companies with this type of case.
ActosCancer.com contains information on Actos, the research and side effects linked to the drug, as well as symptoms and treatment options for bladder cancer and how to find a lawyer who can help you file an actos lawsuit.